These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
92 related articles for article (PubMed ID: 287817)
41. Knowledge is power: legislative control of drug industry trade secrets. O'Reilly JT Spec Law Dig Health Care (Mon); 1987 May; 8(15):7-31. PubMed ID: 10281981 [No Abstract] [Full Text] [Related]
42. Pharmacists' and physicians' responses to the South Carolina Product Selection Act of 1978. Sumner ED; Karig AW; Hunt HH Contemp Pharm Pract; 1982; 5(2):124-9. PubMed ID: 10256911 [TBL] [Abstract][Full Text] [Related]
43. The pharmaceutical industry -- will Canada become a major research centre? Gray C Can Med Assoc J; 1981 Apr; 124(7):910, 914-5, 918 concl. PubMed ID: 7214290 [No Abstract] [Full Text] [Related]
45. Plan defeated, but pharmacists still seek ability to prescribe. Carrell S Am Med News; 1982 May; 25(18):3, 9. PubMed ID: 10324199 [No Abstract] [Full Text] [Related]
46. Mandating unit dose drug distribution and i.v. admixture services in New Jersey hospitals. LaFranco M; Pescatore J Am J Hosp Pharm; 1987 Jun; 44(6):1371-5. PubMed ID: 3618615 [TBL] [Abstract][Full Text] [Related]
47. Generic drugs: cutting cost, not corners. Rados B FDA Consum; 1985 Oct; 19(8):26, 28-9. PubMed ID: 10311663 [No Abstract] [Full Text] [Related]
48. On therapeutic equivalency and the antisubstitution laws. Schiffman DO JAMA; 1973 Jan; 223(5):552-3. PubMed ID: 4739142 [No Abstract] [Full Text] [Related]
49. [Proposed new law on pharmacy]. Ugeskr Laeger; 1953 Nov; 115(47):1745-6. PubMed ID: 13136545 [No Abstract] [Full Text] [Related]
50. MAC--a cutting tool for federal reimbursements on prescription drugs? Hirsh HL J Leg Med (N Y); 1976 Feb; 4(2):31-3. PubMed ID: 1082483 [No Abstract] [Full Text] [Related]
51. Pharmaceuticals issue brief: generic and therapeutic substitution: year end report--2004. Health Policy Tracking Service staff Issue Brief Health Policy Track Serv; 2004 Dec; ():1-14. PubMed ID: 15724310 [No Abstract] [Full Text] [Related]
52. Guidelines for pharmacists performing product selection. Am Pharm; 1990 Jul; NS30(7):40-1. PubMed ID: 2363394 [No Abstract] [Full Text] [Related]
53. Use of 'treatment equivalents' supplements generics in controlling pharmacy costs. Cost Containment; 1980 Feb; 2(3):1. PubMed ID: 10309092 [No Abstract] [Full Text] [Related]
54. Pharmacy and generic substitution of antiepileptic drugs: missing in action? Welty TE Ann Pharmacother; 2007 Jun; 41(6):1065-8. PubMed ID: 17504833 [TBL] [Abstract][Full Text] [Related]
55. Eli Lilly vs. New York. Am Fam Physician; 1978 Sep; 18(3):69-70. PubMed ID: 685799 [No Abstract] [Full Text] [Related]
56. The legal basis for clinical pharmacy practice. DeMarco CT Am J Hosp Pharm; 1973 Nov; 30(11):1067-71. PubMed ID: 4751188 [No Abstract] [Full Text] [Related]
57. Pharmaco-legal considerations in the clinical use of decongestants. Brushwood DB Pharmacotherapy; 1993; 13(6 Pt 2):135S-142S; discussion 143S-146S. PubMed ID: 7507591 [TBL] [Abstract][Full Text] [Related]
58. [Interchange of bioequivalent drugs]. Muñoz de Quiñones A Bol Col Prof Enferm P R; 1982 Sep; 8(31):15-6. PubMed ID: 6965000 [No Abstract] [Full Text] [Related]
59. [Is openness in the drug market possible?]. Dölle W; Schwabe U Internist (Berl); 1986 Jan; 27(1):21-31. PubMed ID: 3514513 [No Abstract] [Full Text] [Related]